{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:35:49Z","timestamp":1789569349995,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Pathologie"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.annpat.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T16:13:59Z","timestamp":1678378439000},"page":"180-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dysplasies conventionnelles et non conventionnelles compliquant les maladies inflammatoires chroniques de l\u2019intestin"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9369-933X","authenticated-orcid":false,"given":"Diana","family":"Enea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Lauwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Svrcek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annpat.2023.02.006_bib0375","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0380","first-page":"1486","article-title":"Clinicopathological and molecular specificities of inflammatory bowel disease-related colorectal neoplastic lesions: the role of inflammation","volume":"12","author":"Svrcek","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0385","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0390","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.annpat.2023.02.006_bib0395","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3748\/wjg.v22.i20.4794","article-title":"Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment","volume":"22","author":"Axelrad","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0400","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2261::AID-CNCR1>3.0.CO;2-Q","article-title":"Significance and detection of dysplasia in chronic colitis","volume":"78","author":"Goldman","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2023.02.006_bib0405","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PAP.0000000000000316","article-title":"The significance of flat\/invisible dysplasia and nonconventional dysplastic subtypes in inflammatory bowel disease: a review of their morphologic, clinicopathologic, and molecular characteristics","volume":"29","author":"Choi","year":"2022","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0410","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/his.14298","article-title":"Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia","volume":"78","author":"Lee","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0415","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41379-019-0419-1","article-title":"Non-conventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study","volume":"33","author":"Choi","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0420","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"de Souza","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0425","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MIB.0000000000000236","article-title":"Cytokines, IBD, and colitis-associated cancer","volume":"21","author":"Francescone","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0430","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1053\/j.gastro.2014.01.001","article-title":"Gastrointestinal malignancy and the microbiome","volume":"146","author":"Abreu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0435","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","article-title":"Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation","volume":"287","author":"Itzkowitz","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0440","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annpat.2023.02.006_bib0445","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0450","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/cncr.10334","article-title":"The APC\/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis","volume":"94","author":"Aust","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2023.02.006_bib0455","first-page":"3333","article-title":"Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease","volume":"60","author":"Hussain","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.annpat.2023.02.006_bib0460","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s10620-014-3373-2","article-title":"The risk of colorectal cancer in patients with ulcerative colitis","volume":"60","author":"Nowacki","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.annpat.2023.02.006_bib0465","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nrgastro.2017.1","article-title":"Clonal evolution of colorectal cancer in IB","volume":"14","author":"Choi","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0470","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gutjnl-2018-316191","article-title":"Evolutionary history of human colitis-associated colorectal cancer","volume":"68","author":"Baker","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.annpat.2023.02.006_bib0475","first-page":"511","article-title":"The histopathological approach to inflammatory bowel disease: a practice guide","volume":"464","author":"Langner","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.annpat.2023.02.006_bib0480","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: a population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.annpat.2023.02.006_bib0485","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/ecco-jcc\/jjx035","article-title":"Anal neoplasia in inflammatory bowel disease: classification proposal, epidemiology, carcinogenesis, and risk management perspectives","volume":"11","author":"Wisniewski","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0490","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/j.gastro.2012.04.054","article-title":"Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010","volume":"143","author":"Herrinton","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0495","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0500","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.876","article-title":"Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis","volume":"194","author":"Eaden","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0505","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.gastro.2003.11.010","article-title":"Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis","volume":"126","author":"Rutter","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0510","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/sj.bjc.6605359","article-title":"Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease","volume":"101","author":"Lutgens","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annpat.2023.02.006_bib0515","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/gut.42.5.711","article-title":"Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study","volume":"42","author":"Karl\u00e9n","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.annpat.2023.02.006_bib0520","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2036.2000.00698.x","article-title":"Colorectal cancer prevention in ulcerative colitis: a case-control study","volume":"14","author":"Eaden","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.annpat.2023.02.006_bib0525","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ajg.2015.65","article-title":"Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview","volume":"110","author":"Choi","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0530","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.gie.2014.12.009","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"81","author":"Laine","year":"2015","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.annpat.2023.02.006_bib0535","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ibd.21687","article-title":"Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy","volume":"18","author":"Kisiel","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0540","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/00365520801909686","article-title":"High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis","volume":"43","author":"Blonski","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0545","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.gie.2006.09.025","article-title":"Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?","volume":"65","author":"Rubin","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.annpat.2023.02.006_bib0550","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.05.063","article-title":"AGA clinical practice update on endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases: expert review","volume":"161","author":"Murthy","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0555","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0016-5085(92)91185-7","article-title":"DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis","volume":"103","author":"Rubin","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0560","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.gie.2017.12.016","article-title":"Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease","volume":"87","author":"Krugliak Cleveland","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.annpat.2023.02.006_bib0565","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2013.07.024","article-title":"Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis","volume":"12","author":"Wanders","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0570","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0016-5107(04)01710-9","article-title":"Most dysplasia in ulcerative colitis is visible at colonoscopy","volume":"60","author":"Rutter","year":"2004","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.annpat.2023.02.006_bib0575","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0016-5085(94)90216-X","article-title":"Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis","volume":"107","author":"Connell","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0580","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/sj.bjc.6601247","article-title":"Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population","volume":"89","author":"Hata","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.annpat.2023.02.006_bib0585","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2036.2007.03241.x","article-title":"Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis","volume":"25","author":"Thomas","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.annpat.2023.02.006_bib0590","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.gastro.2003.08.023","article-title":"Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis","volume":"125","author":"Ullman","year":"2003","journal-title":"Gastroenterology."},{"key":"10.1016\/j.annpat.2023.02.006_bib0595","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ibd.21467","article-title":"Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia","volume":"17","author":"van Schaik","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0600","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1053\/j.gastro.2017.08.031","article-title":"Association of aneuploidy and flat dysplasia with development of high-grade dysplasia or colorectal cancer in patients with inflammatory bowel disease","volume":"153","author":"Tsai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0605","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0610","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/gut.47.2.251","article-title":"The Vienna classification of gastrointestinal epithelial neoplasia","volume":"47","author":"Schlemper","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.annpat.2023.02.006_bib0615","series-title":"Surgical pathology of the GI tract, liver, biliary tract, and pancreas","first-page":"436","article-title":"Inflammatory disorders of the small intestine","author":"Patil","year":"2015"},{"key":"10.1016\/j.annpat.2023.02.006_bib0620","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/00000478-200608000-00014","article-title":"Intestinal low-grade tubuloglandular adenocarcinoma in inflammatory bowel disease","volume":"30","author":"Levi","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0625","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2559.1988.tb02055.x","article-title":"Observer variation in the assessment of dysplasia in ulcerative colitis","volume":"13","author":"Dixon","year":"1988","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0630","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/path.876","article-title":"Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis","volume":"194","author":"Eaden","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0635","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/gut.52.8.1127","article-title":"Ten-year follow-up of ulcerative colitis patients with and without low-grade dysplasia","volume":"52","author":"Lim","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.annpat.2023.02.006_bib0640","doi-asserted-by":"crossref","first-page":"V10","DOI":"10.1136\/gut.51.suppl_5.v10","article-title":"Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease","volume":"51","author":"Eaden","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.annpat.2023.02.006_bib0645","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.crohns.2013.06.001","article-title":"European consensus on the histopathology of inflammatory bowel disease","volume":"7","author":"Magro","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0650","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13402-010-0006-4","article-title":"Biomarker-based prediction of inflammatory bowel disease\u2013related colorectal cancer: a case-control study","volume":"34","author":"Gerrits","year":"2011","journal-title":"Cell Oncol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0655","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2013.133","article-title":"Diagnostic utility of TP53 and cytokeratin 7 immunohistochemistry in idiopathic inflammatory bowel disease\u2013associated neoplasia","volume":"27","author":"Xie","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0660","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ibd.21722","article-title":"Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis","volume":"18","author":"van Schaik","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0665","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1136\/gutjnl-2012-303594","article-title":"Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus","volume":"62","author":"Kastelein","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.annpat.2023.02.006_bib0670","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ecco-jcc\/jjab120","article-title":"Hypermucinous, goblet cell-deficient and crypt cell dysplasias in inflammatory bowel disease are often associated with flat\/invisible endoscopic appearance and advanced neoplasia on follow-up","volume":"16","author":"Choi","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.annpat.2023.02.006_bib0675","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/his.14294","article-title":"Non-conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum","volume":"78","author":"Pereira","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0680","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/gut.45.5.686","article-title":"Villous, hypermucinous mucosa in long standing ulcerative colitis shows high frequency of K-ras mutations","volume":"45","author":"Andersen","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.annpat.2023.02.006_bib0685","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/his.13923","article-title":"DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease","volume":"75","author":"Wen","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.annpat.2023.02.006_bib0690","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jclinpath-2019-206247","article-title":"Histological and molecular diversity and heterogeneity of precancerous lesions associated with inflammatory bowel diseases","volume":"73","author":"Gui","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0695","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0b013e318267b02e","article-title":"Paneth cells in colonic adenomas: association with male sex and adenoma burden","volume":"37","author":"Pai","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0700","doi-asserted-by":"crossref","first-page":"26129","DOI":"10.1038\/srep26129","article-title":"Paneth cell in adenomas of the distal colorectum is inversely associated with synchronous advanced adenoma and carcinoma","volume":"6","author":"Mahon","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.annpat.2023.02.006_bib0705","doi-asserted-by":"crossref","first-page":"355","DOI":"10.14740\/gr1064w","article-title":"Clinical, histologic, and immunophenotypic features of serrated polyps in patients with inflammatory bowel disease","volume":"11","author":"Yang","year":"2018","journal-title":"Gastroenterology Res"},{"key":"10.1016\/j.annpat.2023.02.006_bib0710","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/PAS.0b013e318150d51b","article-title":"Hyperplastic\/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity","volume":"32","author":"Srivastava","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0715","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/modpathol.2015.111","article-title":"Serrated colorectal polyps in inflammatory bowel disease","volume":"28","author":"Ko","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0720","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.humpath.2015.06.019","article-title":"Clinical, pathologic, and outcome study of hyperplastic and sessile serrated polyps in inflammatory bowel disease","volume":"46","author":"Shen","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0725","first-page":"19","article-title":"Serrated colorectal lesions in patients with inflammatory bowel disease","volume":"14","author":"Parian","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.annpat.2023.02.006_bib0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.gie.2015.12.010","article-title":"Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease","volume":"84","author":"Parian","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.annpat.2023.02.006_bib0735","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/apt.12774","article-title":"Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis","volume":"39","author":"Johnson","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.annpat.2023.02.006_bib0370","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/00325481.2020.1802138","article-title":"Significance of serrated epithelial change in inflammatory bowel disease","volume":"133","author":"Batts","year":"2021","journal-title":"Postgrad Med"}],"container-title":["Annales de Pathologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649823000494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0242649823000494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:35:29Z","timestamp":1759332929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0242649823000494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0242649823000494"],"URL":"https:\/\/doi.org\/10.1016\/j.annpat.2023.02.006","relation":{},"ISSN":["0242-6498"],"issn-type":[{"value":"0242-6498","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysplasies conventionnelles et non conventionnelles compliquant les maladies inflammatoires chroniques de l\u2019intestin","name":"articletitle","label":"Article Title"},{"value":"Annales de Pathologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annpat.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}